Skip to content

OPEN Foundation

Menu

Therapist Training
- ADEPT
- Foundations
  - Curriculum
  - Faculty
  - Enrolment
  - FAQ
Conference
Community
Events
Articles & News
About
- Team
- Vacancies
Contact
Donate
Member Login

Search

Articles & News

Search

Search

Scientific Discipline
Substance
Therapeutic Application

Current Status of Ketamine and Related Therapies for Mood and Anxiety Disorders

October 1, 2015

Ketamine for depression: evidence, challenges and promise

September 25, 2015

3,4-Methylenedioxymethamphetamine facilitates fear extinction learning

September 15, 2015

Psychedelic medicine: A re-emerging therapeutic paradigm

September 8, 2015

Ketamine for depression: the highs and lows

September 1, 2015

Psilocybin, psychological distress, and suicidality

September 1, 2015

R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects

September 1, 2015

Noribogaine is a G-Protein Biased κ-Opioid Receptor Agonist

August 21, 2015

5-HT2A and mGlu2/3 receptor interactions: on their relevance to cognitive function and psychosis

August 19, 2015

Psychopharmacological Agents and Suicide Risk Reduction: Ketamine and Other Approaches

August 1, 2015

OPEN is a public benefit organisation (ANBI) and registered charity with the Dutch tax authorities.

Linkedin Twitter Facebook-f Instagram Youtube

OPEN

About
Events
Programmes
Resources
Blog
Newsletter
Privacy Policy
Terms & Conditions
Klachtenregeling
Contact

ABOUT

Mission
Team
Partners
FAQs
Nonprofit Status
Financial Reports
Indegeest Network
Working Group GGZ

EVENTS

ICPR Conference
Online Events
On-site Events

RESOURCES

Talks
Papers
Books

PROGRAMMES

Membership
Training
Research

ACTIONS

Participate
Vacancies
Donate

© 2007-2024 OPEN Foundation

Family Matters & Psychedelics: Bi-directional Impact and Directions for Systems-Informed Care - March 26